Evaluation of paediatric tolerance to an extract of Alternaria alternata under two treatment regimes. A multicentre study

Allergologia et Immunopathologia

Volumn 33, Issue 3, 2005, Pages 138-141

  Martinez Canavate A ^a   Eseverri, J L ^b   Rodenas R ^c   Tabar, A I ^d   Garde, J ^e   Torres, J ^f   Bone J ^g   Pedemonte, C ^h  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^c HOSPITAL LLUÍS ALCANYÍS   (Spain)

^d Universidad Pública de Navarra   (Spain)

^e HOSPITAL GENERAL UNIVERSITARIO DE ELCHE   (Spain)

^f HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^g HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

^h SEICAP Immunotheraphy Committee ^*

Author keywords

Alternaria; Asthma; Children; Imunotherapy; Moulds; Rhinitis

Indexed keywords

ALTERNARIA ALTERNATA EXTRACT; IMMUNOLOGIC AGENT; PANGRAMIN; UNCLASSIFIED DRUG;

ADOLESCENT; ALLERGIC ASTHMA; ALLERGIC RHINITIS; ALTERNARIA; ALTERNARIA ALTERNATA; ARTICLE; ASTHMA; CLINICAL TRIAL; COUGHING; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; ECZEMA; EVALUATION; FEMALE; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOTHERAPY; MAINTENANCE DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NONHUMAN; PRESCHOOL CHILD; RETROSPECTIVE STUDY; RHINITIS; SCHOOL CHILD; TREATMENT OUTCOME; URTICARIA;

EID: 21244492811     PISSN: 03010546     EISSN: None     Source Type: Journal    
DOI: 10.1157/13075696     Document Type: Article

References (11)

1. D'Amato G, Chatzigeorgiou G, Corsico R, Gioulekas D, et al. Position Paper. Evaluation of the prevalence of skin prick test positivity to Alternaria and Cladosporium in patients with suspected respiratory allergy. Allergy. 1997;52:711-6.
2. Criado Molina A, Guerra Pasadas F, Daza Muñoz JC, Moreno Aguilar C, et al. Immunotherapy with an oral Alternaria extrcat in childhood asthma. Clinical safety and efficacy and effects on in vivo and in vitro parameters. Allergologia et Immunopathologia. 2002;30(6):319-30.
3. Tabar AI, Lizaso MT, Garcia BE, Echechipia S, et al. Tolerance of immunotherapy with a standardized extract of Alternaria tenuis in patients with rhinitis and bronchial asthma. J Invest Allergol Clin Immunol. 2000;10(6):327-33.
4. Bernardis P, Agnoletto M, Puccinelli P, Parmiani S, Pozzan M. Injective versus sublingual immunotherapy in Alternaria tenuis allergic patients. J Invest Allergol Clin Immunol. 1996;6(1):55-62.
5. Horst M, Hejjaoui A, Horst V, Michel FB, Bousquet J. Double-blind, placebo-controlled rush immunotherapy with a standardized Alternaria extract. J Allergy Clin Immunol. 1990;85 (2):460-72.
6. Cantani A, Businco E, Maglio A. Alternaria allergy: a three-year controlled study in children treated with immunotherapy. Allergologia et Immunopathologia. 1988;16(1):1-4.
7. Tabar AI, Fernéndez-Távora L, Alonso R, Castillo R, et al. Tolerance of a cluster schedule with a house dust mite extract quantified in mass units: multicentre study. J Invest Allergol Clin Immunol. 2004;14(3):193-7.
8. Gamboa P, González G, Jáuregui I, Jorró G, et al. A prospective and multicenter safety-monitoring study of a short up-dosing schedule of immunotherapy with a mass-units-standardized extract of mites. Allergol et Immunopathol. 2004;32(1):13-7.
9. Moreno C, Fernández-Távora L, Acero S, Alonso MD, et al. Tolerance of a cluster schedule on the treatment of seasonal allergic respiratory disease with pollen extracts quantified in mass units. J Invest Allergol Clin Immunol. 2003;13(4):221-7.
10. Guardia P, Moreno C, Justicia JL, Conde J, et al. Tolerance and short-term effect of a cluster schedule with pollen extracts quantified in mass-units. Allergol et Immunopathol. 2004; 32(5):271-7.
11. Moreno C, Fernández-Távora L, Justicia JL, Cabeza N, Vidal C. Investigation of an adequate immunotherapy initiation schedule with an Alternaria tenuis extract. Alergol Immunol Clin. 2001;16:133-7.